SRD5A1 (3-oxo-5-alpha-steroid 4-dehydrogenase 2) Polyclonal Antibody, APC-Cy7 Conjugated

Katalog-Nummer bs-11308R-APC-Cy7

Size : 100ul

Marke : Bioss

Weitere Informationen anfordern

Contact local distributor :


Telefonnummer : +1 850 650 7790

SRD5A1 (3-oxo-5-alpha-steroid 4-dehydrogenase 2) Polyclonal Antibody, APC-Cy7 Conjugated

Applications

  • WB

Reactivity

  • Human
  • Bovine
  • Sheep
  • Others

Predicted Reactivity

  • Mouse
  • Rat
  • Dog
  • Horse
  • Chicken
Overview
Catalog # bs-11308R-APC-Cy7
Product Name SRD5A1 (3-oxo-5-alpha-steroid 4-dehydrogenase 2) Polyclonal Antibody, APC-Cy7 Conjugated
Applications WB
Reactivity Human, Bovine, Sheep, Others
Predicted Reactivity Mouse, Rat, Dog, Horse, Chicken
Specifications
Conjugation APC-Cy7
Host Rabbit
Source KLH conjugated synthetic peptide derived from human SRD5A1
Immunogen Range 101-200/259
Clonality Polyclonal
Isotype IgG
Concentration 1ug/ul
Purification Purified by Protein A.
Storage Buffer Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage Condition Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Target
Subcellular location Cytoplasm, Cell membrane
Synonyms 3-oxo-5-alpha-steroid 4-dehydrogenase 1; SR type 1; Steroid 5-alpha-reductase 1; S5AR 1; S5A1_HUMAN.
Background Steroid 5a-Reductase is an important enzyme in androgen physiology because it catalyzes the conversion of testosterone into the more potent 5a-dihydro-testosterone, which mediates androgen effects on target tissues. The enzyme exists as two isoforms: type 1, which is expressed mainly in the skin; and type 2, which is expressed mainly in the prostate. In cultured human skin cells, 5a-Reductase 1 shows heterogeneity of protein, and has different levels of transcriptional and translational expression. 5a-Reductase 1 is expressed in all portions of the hair follicle, whereas 5a-Reductase 2 is expressed only in mesenchymal portions. In addition, 5a-Reductase 1 is mainly expressed in human breast carcinoma and may play a role in the in situ production and actions of the potent androgen 5a-dihydrotestosterone, including inhibition of cancer cell proliferation in hormone-dependent human breast carcinoma. The 5a-Reductase-3a-hydroxysteroid dehydrogenase complex is present in the human brain, suggesting that the complex may be involved in the synthesis of neuroactive steroids or the catabolism of neurotoxic steroids.
Application Dilution
WB 1:300-5000